April 24, 2007 - GE Healthcare recently announced it has received clearance from the FDA for the company's next-generation volume PET/CT application, PET VCAR (Volume Computer-Assisted Reading), created to help clinicians diagnose, stage, treat and monitor tumors and other lesions in the body.
PET VCAR offers several workflow enhancements for both single- and multi-exam review, including exam-to-exam auto-registration, tumor segmentation and quantification, and multi-planar image review.
The FDA clearance includes a GE-patented Interactive Data Analysis (IDA) tool, which allows physicians to systematically track treatment over time and quantitatively interpret a patient's response to therapy. The new IDA capability reportedly facilitates informed, objective treatment decision-making by automating several previously manual processes and presenting data in an organized, user-configurable format.
October 19, 2026 
